Viewing Study NCT05903118


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2025-12-26 @ 3:58 AM
Study NCT ID: NCT05903118
Status: COMPLETED
Last Update Posted: 2024-01-10
First Post: 2023-06-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase I/II Study to Evaluate a SARS-CoV-2 mRNA Vaccine in Healthy Adults
Sponsor: Argorna Pharmaceuticals Co., LTD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module